By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous coagulation modifiers > Tranexamic acid (lysteda) > Tranexamic Acid Dosage
Miscellaneous coagulation modifiers
https://themeditary.com/dosage-information/tranexamic-acid-dosage-12391.html

Tranexamic Acid Dosage

Drug Detail:Tranexamic acid (lysteda) (Tranexamic acid (lysteda) [ tran-ex-am-ik-as-id ])

Drug Class: Miscellaneous coagulation modifiers

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Bleeding

Initial dose: 10 mg/kg intravenously, immediately before dental extraction
Maintenance dose: 10 mg/kg intravenously three to four times daily
Duration of therapy: 2 to 8 days

Comments: Infuse no more than 1 mL/minute to avoid hypotension.

Use: Short-term use in patients with hemophilia to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following a tooth extraction.

Usual Adult Dose for Menstrual Disorders

Dose: 1300 mg (two 650 mg tablets) orally three times a day (3900 mg/day) during monthly menstruation
Duration: Maximum of 5 days

Use: For the treatment of cyclic heavy menstrual bleeding

Usual Pediatric Dose for Bleeding

Initial dose: 10 mg/kg intravenously, immediately before dental extraction
Maintenance dose: 10 mg/kg intravenously three to four times daily
Duration of therapy: 2 to 8 days

Comments:

  • The limited data suggest that dosing instructions for adults can be used for pediatric patients needing therapy for tooth extractions.
  • Infuse no more than 1 mL/minute to avoid hypotension.

Use: Short-term use in patients with hemophilia to reduce or prevent hemorrhage and reduce the need for replacement therapy during tooth extractions.

Usual Pediatric Dose for Menstrual Disorders

Post menarchal females:

Dose: 1300 mg (two 650 mg tablets) orally three times a day (3900 mg/day) during monthly menstruation

Duration: Maximum of 5 days

Use: For the treatment of cyclic heavy menstrual bleeding in post-menarchal females

Renal Dose Adjustments

Oral:
Serum creatinine above 1.4 mg/dL and less than or equal to 2.8 mg/dL: 1300 mg (two 650 mg tablets) orally two times a day for a maximum of 5 days during menstruation
Serum creatinine above 2.8 mg/dL and less than or equal to 5.7 mg/dL: 1300 mg (two 650 mg tablets) orally once a day for a maximum of 5 days during menstruation
Serum creatinine above 5.7 mg/dL: 650 mg (one 650 mg tablet) orally once a day for a maximum of 5 days during menstruation

Intravenous:
Serum creatinine 1.4 to less than 2.8 mg/dL: 10 mg/kg intravenously twice a day
Serum creatinine 2.8 to less than 5.7 mg/dL: 10 mg/kg intravenously once a day
Serum creatinine greater than 5.7 mg/dL: 5 mg/kg intravenously every 24 hours

Liver Dose Adjustments

No dose adjustment is needed.

Precautions

CONTRAINDICATION:
Intravenous injection:

  • Hypersensitivity to the active component or any of the ingredients
  • Patients with subarachnoid hemorrhage, due to risk of cerebral edema and cerebral infarction
  • Active intravascular clotting

Oral:
  • Hypersensitivity to the active component or any of the ingredients
  • Women who are using combination hormonal contraception
  • Women with active thromboembolic disease or a history or intrinsic risk of thrombosis or thromboembolism, including retinal vein or artery occlusion

The oral formulation is not indicated for use in women before menarche and is not intended for postmenopausal women.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Intravenous infusion speed should be no more than 1 mL/minute to avoid hypotension.
  • The intravenous injection is for IV use only, and serious adverse reactions can occur if administered intrathecally (seizures and cardiac arrhythmias). Confirm route of administration and avoid confusion with other injectables and clearly label for IV route of administration.

Storage requirements:
  • The manufacturer product information should be consulted.

Patient advice:
  • This drug may cause dizziness. Avoid driving, operating machinery, or performing hazardous tasks while taking it until you know how will affect you.
  • Report any eye symptoms or changes in your vision to your healthcare provider and follow-up with an ophthalmologist for a complete ophthalmologic evaluation.
  • Female patients: Using hormonal contraception combined with tranexamic acid injection may increase the risk for thromboembolic adverse reactions. Consider using an effective alternative (nonhormonal) contraception during therapy.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by